Parallel Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
LG
Parallel Advisors's AMPH Position: Q2 2026 in Review
Parallel Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 355% in Q2 2026, buying an estimated $47K and bringing the position to 2,988 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.
Parallel Advisors first reported a position in AMPH in Q3 2021 and has held it in 20 quarters since. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Parallel Advisors held 2,988 shares of Amphastar Pharmaceuticals worth $60.3K as of Q2 2026.
- Parallel Advisors bought 2,331 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $47K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2015 holding.
- Parallel Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
- 82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.